Westmount Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $481K | Buy |
10,395
+11
| +0.1% | +$509 | 0.13% | 130 |
|
|
2025
Q1 | $633K | Buy |
10,384
+9
| +0.1% | +$549 | 0.19% | 107 |
|
|
2024
Q4 | $587K | Buy |
10,375
+10
| +0.1% | +$566 | 0.18% | 105 |
|
|
2024
Q3 | $536K | Sell |
10,365
-100
| -1% | -$5.17K | 0.16% | 109 |
|
|
2024
Q2 | $432K | Buy |
10,465
+123
| +1% | +$5.08K | 0.14% | 123 |
|
|
2024
Q1 | $561K | Sell |
10,342
-190
| -2% | -$10.3K | 0.2% | 104 |
|
|
2023
Q4 | $540K | Sell |
10,532
-1,254
| -11% | -$64.3K | 0.22% | 98 |
|
|
2023
Q3 | $684K | Buy |
11,786
+679
| +6% | +$39.4K | 0.3% | 79 |
|
|
2023
Q2 | $710K | Buy |
11,107
+277
| +3% | +$17.7K | 0.31% | 69 |
|
|
2023
Q1 | $751K | Buy |
10,830
+8
| +0.1% | +$554 | 0.35% | 66 |
|
|
2022
Q4 | $779K | Buy |
+10,822
| New | +$779K | 0.4% | 55 |
|